Our Approach to Innovation
 

With Omnipod® 5 we created the first and only tubeless Automated Insulin Delivery (AID) system in the US, but we’re not stopping there. We’re continuing to lead the tubeless pump revolution by diligently working on offering our consumers a choice of phone operating system for the Omnipod 5 App and also sensor of choice among the biggest sensors available on the market.

We have groundbreaking news that Omnipod 5 is now indicated for people with type 2 diabetes (ages 18 years and older) in the United States! This makes it the first and only automated insulin delivery system FDA-cleared for both type 1 and type 2 diabetes management. For any questions, read our FAQs here.

We're excited to announce that Omnipod 5 integration with Dexcom G7 is now broadly available in retail pharmacies across the U.S.! This is another step toward our goal of offering Omnipod 5 users a choice of CGM sensor. For any questions, read our FAQs here.

The Omnipod® 5 System is now integrated with the FreeStyle Libre 2 Plus Sensor! With this new sensor integration, users will benefit from tubeless automated insulin delivery along with the convenience of a 15-day wear CGM sensor, and the ability to start, deactivate, and view sensor glucose data directly from the Omnipod 5 Controller. FAQs here

We are proud to partner with Dexcom and Abbott to expand our Omnipod 5 sensor integration options, giving users choice in the device they use for glucose monitoring.

• Omnipod 5 type 2 diabetes indication
• Dexcom G7 and Omnipod
• FreeStyle Libre 2 Plus Sensor and Omnipod 5
• Omnipod App for iPhone (iOS)